Greece vs Norway: Incidence of tuberculosis
Incidence of tuberculosis over time
- Greece
- Norway
How they compare
Greece currently reports 3.6 per 100,000 people against 3.3 per 100,000 people in Norway, a difference of 0.3 per 100,000 people.
That makes Greece's figure about 1.1 times Norway's.
The two have swapped places 8 times across 25 shared years of data; in 2000 it was Greece ahead.
Greece ranks 183rd and Norway ranks 185th of 208 countries.
Across the 3 decades both report, Greece averaged higher in 2 and Norway in 1.
Head to head by decade
| Decade | Greece | Norway | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 7.98 per 100,000 people | 7.76 per 100,000 people | 0.22 per 100,000 people | Greece |
| 2010s | 5.43 per 100,000 people | 6.3 per 100,000 people | 0.87 per 100,000 people | Norway |
| 2020s | 3.9 per 100,000 people | 3.08 per 100,000 people | 0.82 per 100,000 people | Greece |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher incidence of tuberculosis, Greece or Norway?
- Greece, at 3.6 per 100,000 people against 3.3 per 100,000 people in Norway as of 2024.
- What is the difference in incidence of tuberculosis between Greece and Norway?
- 0.3 per 100,000 people, with Greece ahead.
- How many years of comparable data are there for Greece and Norway?
- 25 years are reported by both, from 2000 to 2024.
- How do Greece and Norway rank globally for incidence of tuberculosis?
- Greece ranks 183rd and Norway ranks 185th of 208 countries.
- Where does this data come from?
- Global Tuberculosis Report, World Health Organization (WHO), published as Incidence of tuberculosis (per 100,000 people). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Incidence of tuberculosis is the estimated number of new and relapse tuberculosis cases arising in a given year, expressed as the rate per 100,000 population. All forms of TB are included, including cases in people living with HIV. Estimates for all years are recalculated as new information becomes available and techniques are refined, so they may differ from those published previously.